Current management of advanced non-small cell lung cancer: targeted therapy.
about
Regression of murine lung tumors by the let-7 microRNANew molecularly targeted therapies for lung cancerMolecular testing in lung cancer in the era of precision medicinePhase II trial of sequential gefitinib after minor response or partial response to chemotherapy in Chinese patients with advanced non-small-cell lung cancer.Brain metastasis development and poor survival associated with carcinoembryonic antigen (CEA) level in advanced non-small cell lung cancer: a prospective analysisTranscriptome profiles of carcinoma-in-situ and invasive non-small cell lung cancer as revealed by SAGERadiogenomics predicting tumor responses to radiotherapy in lung cancerOncogenic KRAS-induced interleukin-8 overexpression promotes cell growth and migration and contributes to aggressive phenotypes of non-small cell lung cancer.Pharmacodynamic analysis of tumour perfusion assessed by 15O-water-PET imaging during treatment with sunitinib malate in patients with advanced malignancies.Epidermal growth factor receptor inhibition and non-small cell lung cancer.Current status of vandetanib (ZD6474) in the treatment of non-small cell lung cancerGene expression profiling of epidermal growth factor receptor/KRAS pathway activation in lung adenocarcinoma.Protein farnesyltransferase-catalyzed isoprenoid transfer to peptide depends on lipid size and shape, not hydrophobicity.MiR-378 and MiR-1827 Regulate Tumor Invasion, Migration and Angiogenesis in Human Lung Adenocarcinoma by Targeting RBX1 and CRKL, Respectively.PET Imaging-Based Phenotyping as a Predictive Biomarker of Response to Tyrosine Kinase Inhibitor Therapy in Non-small Cell Lung Cancer: Are We There Yet?[Advances of ectopic ACTH syndrome complicated by lung cancer].
P2860
Q24621218-7DEB6C18-C764-4ACF-8791-1A65D551274EQ24680988-278CA279-DA12-4431-A8E3-3A0F0B9AC379Q26824599-924DDF8D-122B-40E5-8CE5-2EF92031C3FFQ33266837-47CA0971-2B75-4455-A528-E95EFDB2CFB4Q33433688-EBFF0730-0A4A-4953-AC23-3BB7257210EAQ33531797-918B2742-0D75-4E4E-B0C4-C68A2C332BF4Q34049363-39C37412-D3B8-4FCB-87D3-22E62568CDBDQ36030366-050F2A43-324C-41B4-B2D5-91C89B651FADQ36308998-442B994A-EF11-4F55-ABFD-2C653AE8BB40Q36504349-530CBCE7-90B4-43FA-8EE8-9591504ECCD5Q37790985-E435A137-1568-4988-B137-A4EEA08AA9E1Q40141195-38A3AA54-8BA2-4C4C-9EB3-B380F3048470Q42122074-5FEBC41C-9201-4FA2-B011-7EC2CCFF377DQ49396552-694E4FA0-432D-4C5C-8A3E-7F723D92DB59Q50326521-6FA0AD01-CB40-4E7B-BCE2-2216619C0B9EQ55444757-ABEC3A03-0197-43A6-AFDD-05F1FDDF466D
P2860
Current management of advanced non-small cell lung cancer: targeted therapy.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Current management of advanced non-small cell lung cancer: targeted therapy.
@ast
Current management of advanced non-small cell lung cancer: targeted therapy.
@en
type
label
Current management of advanced non-small cell lung cancer: targeted therapy.
@ast
Current management of advanced non-small cell lung cancer: targeted therapy.
@en
prefLabel
Current management of advanced non-small cell lung cancer: targeted therapy.
@ast
Current management of advanced non-small cell lung cancer: targeted therapy.
@en
P1433
P1476
Current management of advanced non-small cell lung cancer: targeted therapy.
@en
P2093
Takeshi Isobe
P304
P356
10.1053/J.SEMINONCOL.2005.02.016
P577
2005-06-01T00:00:00Z